GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » Price-to-Tangible-Book

Lyka Labs (BOM:500259) Price-to-Tangible-Book : (As of May. 27, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs Price-to-Tangible-Book?

As of today (2024-05-27), Lyka Labs's share price is ₹109.00. Lyka Labs's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was ₹0.00. Hence, Lyka Labs's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Lyka Labs's Price-to-Tangible-Book or its related term are showing as below:

BOM:500259' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.98   Med: 10.16   Max: 12.96
Current: 6.98

During the past 13 years, Lyka Labs's highest Price to Tangible Book Ratio was 12.96. The lowest was 6.98. And the median was 10.16.

BOM:500259's Price-to-Tangible-Book is ranked worse than
81.24% of 1221 companies
in the Biotechnology industry
Industry Median: 2.8 vs BOM:500259: 6.98

A closely related ratio is called PB Ratio. As of today, Lyka Labs's share price is ₹109.00. Lyka Labs's Book Value per Sharefor the quarter that ended in Dec. 2023 was ₹0.00. Hence, Lyka Labs's P/B Ratio of today is .


Lyka Labs Price-to-Tangible-Book Historical Data

The historical data trend for Lyka Labs's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Price-to-Tangible-Book Chart

Lyka Labs Annual Data
Trend Mar13 Jun14 Jun15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 12.96

Lyka Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 12.96 - 7.36 -

Competitive Comparison of Lyka Labs's Price-to-Tangible-Book

For the Biotechnology subindustry, Lyka Labs's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lyka Labs's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Lyka Labs's Price-to-Tangible-Book falls into.



Lyka Labs Price-to-Tangible-Book Calculation

Lyka Labs's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=109.00/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Lyka Labs Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Lyka Labs (BOM:500259) Business Description

Traded in Other Exchanges
Address
30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines